Coramed Technologies, LLC

Presenting Coramed Technologies
Coramed Technologies was launched in 2008 by the founders of Haemoscope Corporation, creators of the currently marketed TEG® 5000 hemostasis analyzer. While the TEG 5000 is a successful, industry-leading instrument, it can only be used in a laboratory or hospital setting. Coramed is developing new CORA™ technology that will lead to a smaller, easier-to-use, CLIA-waived device that can be operated virtually anywhere.

Eli Cohen, Ph.D., Co-founder and CEO
Dr. Cohen brings more than 30 years of experience leading medical instrument and software firms, as well as a decade as an educator, to his work at Coramed. He began his career teaching courses in statistics and research methodology at Northwestern University, before co-founding his own database management company in 1980. After 11 years in software, Dr. Cohen a co-founded Haemoscope Corporation, makers of the TEG family of coagulation measurement instruments. By November 2007, Haemoscope sold its TEG technology, including patents and trademarks and its manufacturing and distribution arm to Haemonetics Corporation (symbol “HAE”) and renamed itself Coramed Technologies, LLC.